1. Disease-free survival in the placebo group was 50.7 months and was never reached in the intervention group; however, there ...
1. Risk of major adverse cardiac events increased amongst patients with a specific glomerular disease, including non-proliferative glomerulopathy, renal vascular ...
1. The mean eGFR slope was comparable among patients allocated to sodium bicarbonate and placebo over 24 months. 2. Sodium ...
The experience of spirituality may positively impact the lives of terminal cancer patients 1. In this study, individuals were found ...
1. In a group of patients undergoing endoscopic removal of symptomatic kidney stones, concurrent removal of asymptomatic stones significantly reduced ...
1. This randomized controlled trial found that giving dexmedetomidine for 24 hours at the time of kidney transplant receipt reduced ...
1. This randomized controlled trial found that high dose methylprednisolone for 6-9 months reduced rates of significantly declining kidney function, ...
Patients receiving adjuvant pembrolizumab after nephrectomy for renal-cell carcinoma showed significantly improved disease-free survival compared to patients receiving placebo treatment. ...
1. Lenvatinib plus pembrolizumab was superior to sunitinib in overall survival for patients with advanced renal cell carcinoma. 2. Lenvatinib ...
1. Urate reduction with allopurinol did not slow the decline of estimated glomerular filtration rate (eGFR) compared to the placebo ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.